Anti-Human ICAM-1 – DyLight® 650

Purified Recombinant Human ICAM-1 (>98%)

This DyLight® 650 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.

This DyLight^® 650 conjugate is stable when stored at 2-8°C. Do not freeze.

Next Day 2-8°C

Red Laser (652 nm)

Clone 15.2 recognizes an epitope on human ICAM-1.

ICAM-1 is a 55 kDa glycoprotein that is part of the Ig superfamily. It is heavily glycosylated to form 75 kDa to 115 kDa. ICAM-1 is known to be an adhesion and viral entry molecule, and its long suspected involevement in signal transduction is being elucidated. The signal-transducing functions of ICAM-1 appear to be mainly associated with proinflammatory pathways. Furthermore, ICAM-1 signaling appears to act as a beacon for inflammatory immune cells such as macrophages and granulocytes bringing about inflammation via lymphocyte trafficking. ICAM-1 is essential for the transmigration of leukocytes out of blood vessels and into tissues, and is a marker of endothelial dysfunction leading to damaging vascular disorders in umbilical and placental vascular tissue of gestational pregnancies. ICAM-1 is the receptor for rhinoviruses (the cause of most common colds) and malaria, and plays an inflammatory role in ocular allergies.

CD54 is present on endothelial cells, lymphocytes, epithelial cells, dendritic cells and keratinocytes.

1. Li, S. et al. (2009) Biochem Biophys Res Commun. 381: 459 2. Wolf, S. et al. (2009) Pharmacol Rep 61: 22 3. Ozcan, U. et al. (2009) Arch Gynecol Obstet.